These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 33672887)

  • 1. Fungi-Bacteria Correlation in Alcoholic Hepatitis Patients.
    Gao B; Zhang X; Schnabl B
    Toxins (Basel); 2021 Feb; 13(2):. PubMed ID: 33672887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in the fecal bacterial microbiota associated with disease severity in alcoholic hepatitis patients.
    Lang S; Fairfied B; Gao B; Duan Y; Zhang X; Fouts DE; Schnabl B
    Gut Microbes; 2020 Nov; 12(1):1785251. PubMed ID: 32684075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intestinal Fungal Dysbiosis and Systemic Immune Response to Fungi in Patients With Alcoholic Hepatitis.
    Lang S; Duan Y; Liu J; Torralba MG; Kuelbs C; Ventura-Cots M; Abraldes JG; Bosques-Padilla F; Verna EC; Brown RS; Vargas V; Altamirano J; Caballería J; Shawcross D; Lucey MR; Louvet A; Mathurin P; Garcia-Tsao G; Ho SB; Tu XM; Bataller R; Stärkel P; Fouts DE; Schnabl B
    Hepatology; 2020 Feb; 71(2):522-538. PubMed ID: 31228214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Supplementation of saturated long-chain fatty acids maintains intestinal eubiosis and reduces ethanol-induced liver injury in mice.
    Chen P; Torralba M; Tan J; Embree M; Zengler K; Stärkel P; van Pijkeren JP; DePew J; Loomba R; Ho SB; Bajaj JS; Mutlu EA; Keshavarzian A; Tsukamoto H; Nelson KE; Fouts DE; Schnabl B
    Gastroenterology; 2015 Jan; 148(1):203-214.e16. PubMed ID: 25239591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut microbiota dysbiosis in patients with non-alcoholic fatty liver disease.
    Shen F; Zheng RD; Sun XQ; Ding WJ; Wang XY; Fan JG
    Hepatobiliary Pancreat Dis Int; 2017 Aug; 16(4):375-381. PubMed ID: 28823367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fecal Bacteria Implicated in Biofilm Production Are Enriched and Associate to Gastrointestinal Symptoms in Patients With APECED - A Pilot Study.
    Hetemäki I; Jian C; Laakso S; Mäkitie O; Pajari AM; de Vos WM; Arstila TP; Salonen A
    Front Immunol; 2021; 12():668219. PubMed ID: 34367134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microbiome Signatures Associated With Steatohepatitis and Moderate to Severe Fibrosis in Children With Nonalcoholic Fatty Liver Disease.
    Schwimmer JB; Johnson JS; Angeles JE; Behling C; Belt PH; Borecki I; Bross C; Durelle J; Goyal NP; Hamilton G; Holtz ML; Lavine JE; Mitreva M; Newton KP; Pan A; Simpson PM; Sirlin CB; Sodergren E; Tyagi R; Yates KP; Weinstock GM; Salzman NH
    Gastroenterology; 2019 Oct; 157(4):1109-1122. PubMed ID: 31255652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic manipulation of gut microbiota by polysaccharides of
    Sun S; Wang K; Sun L; Cheng B; Qiao S; Dai H; Shi W; Ma J; Liu H
    Gut Microbes; 2020 Nov; 12(1):1830693. PubMed ID: 33106075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fecal Microbiome Distinguishes Alcohol Consumption From Alcoholic Hepatitis But Does Not Discriminate Disease Severity.
    Smirnova E; Puri P; Muthiah MD; Daitya K; Brown R; Chalasani N; Liangpunsakul S; Shah VH; Gelow K; Siddiqui MS; Boyett S; Mirshahi F; Sikaroodi M; Gillevet P; Sanyal AJ
    Hepatology; 2020 Jul; 72(1):271-286. PubMed ID: 32056227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intestinal HIF-1α deletion exacerbates alcoholic liver disease by inducing intestinal dysbiosis and barrier dysfunction.
    Shao T; Zhao C; Li F; Gu Z; Liu L; Zhang L; Wang Y; He L; Liu Y; Liu Q; Chen Y; Donde H; Wang R; Jala VR; Barve S; Chen SY; Zhang X; Chen Y; McClain CJ; Feng W
    J Hepatol; 2018 Oct; 69(4):886-895. PubMed ID: 29803899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The circulating microbiome signature and inferred functional metagenomics in alcoholic hepatitis.
    Puri P; Liangpunsakul S; Christensen JE; Shah VH; Kamath PS; Gores GJ; Walker S; Comerford M; Katz B; Borst A; Yu Q; Kumar DP; Mirshahi F; Radaeva S; Chalasani NP; Crabb DW; Sanyal AJ;
    Hepatology; 2018 Apr; 67(4):1284-1302. PubMed ID: 29083504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Links of gut microbiota composition with alcohol dependence syndrome and alcoholic liver disease.
    Dubinkina VB; Tyakht AV; Odintsova VY; Yarygin KS; Kovarsky BA; Pavlenko AV; Ischenko DS; Popenko AS; Alexeev DG; Taraskina AY; Nasyrova RF; Krupitsky EM; Shalikiani NV; Bakulin IG; Shcherbakov PL; Skorodumova LO; Larin AK; Kostryukova ES; Abdulkhakov RA; Abdulkhakov SR; Malanin SY; Ismagilova RK; Grigoryeva TV; Ilina EN; Govorun VM
    Microbiome; 2017 Oct; 5(1):141. PubMed ID: 29041989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corticosteroids, nutrition, pentoxifylline, or fecal microbiota transplantation for severe alcoholic hepatitis.
    Philips CA; Phadke N; Ganesan K; Ranade S; Augustine P
    Indian J Gastroenterol; 2018 May; 37(3):215-225. PubMed ID: 29931479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Candida albicans exotoxin candidalysin promotes alcohol-associated liver disease.
    Chu H; Duan Y; Lang S; Jiang L; Wang Y; Llorente C; Liu J; Mogavero S; Bosques-Padilla F; Abraldes JG; Vargas V; Tu XM; Yang L; Hou X; Hube B; Stärkel P; Schnabl B
    J Hepatol; 2020 Mar; 72(3):391-400. PubMed ID: 31606552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease.
    Duan Y; Llorente C; Lang S; Brandl K; Chu H; Jiang L; White RC; Clarke TH; Nguyen K; Torralba M; Shao Y; Liu J; Hernandez-Morales A; Lessor L; Rahman IR; Miyamoto Y; Ly M; Gao B; Sun W; Kiesel R; Hutmacher F; Lee S; Ventura-Cots M; Bosques-Padilla F; Verna EC; Abraldes JG; Brown RS; Vargas V; Altamirano J; Caballería J; Shawcross DL; Ho SB; Louvet A; Lucey MR; Mathurin P; Garcia-Tsao G; Bataller R; Tu XM; Eckmann L; van der Donk WA; Young R; Lawley TD; Stärkel P; Pride D; Fouts DE; Schnabl B
    Nature; 2019 Nov; 575(7783):505-511. PubMed ID: 31723265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bile acid homeostasis and intestinal dysbiosis in alcoholic hepatitis.
    Ciocan D; Voican CS; Wrzosek L; Hugot C; Rainteau D; Humbert L; Cassard AM; Perlemuter G
    Aliment Pharmacol Ther; 2018 Nov; 48(9):961-974. PubMed ID: 30144108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intestinal fungi contribute to development of alcoholic liver disease.
    Yang AM; Inamine T; Hochrath K; Chen P; Wang L; Llorente C; Bluemel S; Hartmann P; Xu J; Koyama Y; Kisseleva T; Torralba MG; Moncera K; Beeri K; Chen CS; Freese K; Hellerbrand C; Lee SM; Hoffman HM; Mehal WZ; Garcia-Tsao G; Mutlu EA; Keshavarzian A; Brown GD; Ho SB; Bataller R; Stärkel P; Fouts DE; Schnabl B
    J Clin Invest; 2017 Jun; 127(7):2829-2841. PubMed ID: 28530644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alcohol-related changes in the intestinal microbiome influence neutrophil infiltration, inflammation and steatosis in early alcoholic hepatitis in mice.
    Lowe PP; Gyongyosi B; Satishchandran A; Iracheta-Vellve A; Ambade A; Kodys K; Catalano D; Ward DV; Szabo G
    PLoS One; 2017; 12(3):e0174544. PubMed ID: 28350851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut Mycobiota Dysbiosis in Pulmonary Tuberculosis Patients Undergoing Anti-Tuberculosis Treatment.
    Cao D; Liu W; Lyu N; Li B; Song W; Yang Y; Zhu J; Zhang Z; Zhu B
    Microbiol Spectr; 2021 Dec; 9(3):e0061521. PubMed ID: 34908436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Effects of an Environmentally Relevant Level of Arsenic on the Gut Microbiome and Its Functional Metagenome.
    Chi L; Bian X; Gao B; Tu P; Ru H; Lu K
    Toxicol Sci; 2017 Dec; 160(2):193-204. PubMed ID: 28973555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.